receiving weekly paclitaxel monotherapy for 12 weeks in the outpatient oncology clinics at one of the participating hospital centers
providing signed informed consent
You may not be if
individuals who have experienced a grade 1 or higher hypersensitivity reaction according to CTCAE criteria (Appendix 3) during one of the first two doses of paclitaxel
individuals with metastatic cancer
individuals using chronic oral corticosteroids for more than 2 weeks,
individuals with a contraindication to the use of any of the premedication agents or their ingredients,
pregnant women,
individuals with a language or comprehension barrier to the questionnaires available in French or English, and
individuals participating in another clinical study.
Clareo Health | IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life
